INDP
Indaptus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.22
+5.17%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-67.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Mar 24, 2026 | Lazar David E. · director | Sale | 700,000 | $0.00 |
| Mar 24, 2026 | Lazar David E. · director | Sale | 196,800 | $0.00 |
| Feb 27, 2026 | Jabbour Jerome D · director | A-Award | 25,000 | $2.06 |
| Feb 13, 2026 | Meckler Jeffrey A · director, officer: Co-Chief Executive Officer | A-Award | 12,136 | $1.75 |
| Feb 13, 2026 | Meckler Jeffrey A · director, officer: Co-Chief Executive Officer | A-Award | 1,519 | $1.75 |
| Feb 13, 2026 | Meckler Jeffrey A · director, officer: Co-Chief Executive Officer | A-Award | 3,033 | $1.75 |
| Jan 22, 2026 | NATAN DAVID · director | A-Award | 25,000 | $2.69 |
| Jan 22, 2026 | Ben-Tzvi Avraham · director | A-Award | 25,000 | $0.00 |
| Dec 29, 2025 | Linscott Walt Addison · officer: Chief Operating Officer | A-Award | 54,421 | $2.03 |
| Dec 29, 2025 | Newman Michael James · director, officer: CSO and Director | A-Award | 52,204 | $2.03 |
| Dec 29, 2025 | Meckler Jeffrey A · director, 10 percent owner, officer: Co-Chief Executive Officer | A-Award | 216,617 | $2.03 |
| Dec 29, 2025 | Sassi Nir · officer: Chief Financial Officer | A-Award | 26,758 | $2.03 |
| Jul 29, 2025 | Meckler Jeffrey A · director, officer: Chief Executive Officer | A-Award | 6,068 | $8.30 |
| Jul 29, 2025 | Meckler Jeffrey A · director, officer: Chief Executive Officer | A-Award | 12,136 | $8.30 |
| Jun 11, 2025 | MADDALUNA ANTHONY J · director | A-Award | 12,500 | $0.33 |
| Jun 11, 2025 | Pomerantz Roger · director | A-Award | 30,000 | $0.33 |
| Jun 11, 2025 | Gilbert Mark John · director | A-Award | 12,500 | $0.33 |
| Jun 11, 2025 | Karah Hila · director | A-Award | 12,500 | $0.33 |
| Jun 11, 2025 | Hayes William B · director | A-Award | 12,500 | $0.33 |
| Jun 11, 2025 | Martell Robert · director | A-Award | 12,500 | $0.33 |
| Nov 26, 2024 | Meckler Jeffrey A · director, officer: CEO and Director | A-Award | 42,553 | $1.18 |
| Oct 10, 2024 | Linscott Walt Addison · officer: Chief Operating Officer | A-Award | 75,000 | $1.10 |
| Oct 10, 2024 | Newman Michael James · director, 10 percent owner, officer: CSO and Director | A-Award | 75,000 | $1.10 |
| Oct 10, 2024 | Sassi Nir · officer: Chief Financial Officer | A-Award | 75,000 | $1.10 |
| Oct 10, 2024 | Waltzman Roger J. · officer: Chief Medical Officer | A-Award | 75,000 | $1.10 |
| Oct 10, 2024 | Meckler Jeffrey A · director, officer: CEO and Director | A-Award | 75,000 | $1.10 |
| Aug 8, 2024 | Meckler Jeffrey A · director, officer: CEO and Director | A-Award | 84,932 | $1.82 |
| Jun 7, 2024 | MADDALUNA ANTHONY J · director | A-Award | 12,500 | $2.63 |
| Jun 7, 2024 | Martell Robert · director | A-Award | 12,500 | $2.63 |
| Jun 7, 2024 | Hayes William B · director | A-Award | 12,500 | $2.63 |
Institutional positioning
13F filings over the trailing two quarters
New 4Increased 0Reduced 1Sold out 5
| Filer | Action | Shares | Filed |
|---|---|---|---|
| CITADEL ADVISORS LLC | New Position | 39,018 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | New Position | 27,007 | May 15, 2026 |
| MORGAN STANLEY | New Position | 2,697 | May 15, 2026 |
| TOWER RESEARCH CAPITAL LLC (TRC) | Reduced | 1,890 | May 15, 2026 |
| SBI SECURITIES CO., LTD. | Unchanged | 17 | Apr 28, 2026 |
| CWM, LLC | New Position | 2 | May 14, 2026 |
| CITADEL ADVISORS LLC | Sold Out | 0 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Sold Out | 0 | May 15, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 15, 2026 |
| SBI Securities Co., Ltd. | Sold Out | 0 | Apr 28, 2026 |
| Tower Research Capital LLC (TRC) | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Mar 24, 2026